PT  - JOURNAL ARTICLE
AU  - Simona, Simona
TI  - Globalisation and Maternal Health Care Utilisation in sub-Saharan Africa: A Bayesian Multilevel Analysis
AID  - 10.1101/2022.06.02.22275939
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.06.02.22275939
4099  - http://medrxiv.org/content/early/2022/06/03/2022.06.02.22275939.short
4100  - http://medrxiv.org/content/early/2022/06/03/2022.06.02.22275939.full
AB  - Background Globalization is considered a major structural determinant of health and health care outcomes across the world. This study examines the influence of globalisation on maternal healthcare utilisation in sub-Saharan Africa.Methods Cross-sectional pooled survey data from 34 Demographic and Health Surveys (DHS) with 22559 randomly selected women of reproductive age group with a recent birth were combined with country-level globalisation indices from the KOF Swiss Economic Institute. Bayesian multilevel models were applied on maternal health care utilisation indicators (antenatal care visits, institutional delivery, and postnatal care check-ups) in relation to three dimensions of globalisation indices (economic, social, and political) and selected covariates.Results The results from the study demonstrate that the influence of globalisation on maternal healthcare depends on the dimension of globalisation. After controlling for selected individual and community-level factors, social globalisation is significantly associated with all the indicators of maternal healthcare utilisation while economic globalisation is significantly associated with antenatal care and postnatal check-ups for mothers and new-born babies.Conclusion More consideration in terms of public policy and further research, should be given to dimensions of globalisation which are more likely to influence maternal healthcare utilisation in sub-Saharan Africa.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data is publicly available with permission from https://bit.ly/3NpP3UJ and https://bit.ly/3PqrcpBI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study and publicly available and no further ethical approval was needed https://bit.ly/3PqrcpB https://bit.ly/3NpP3UJ